FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly oncology. An autologous cell vaccine consists of two parts: one contains an attached fraction that is mature dendritic cells (DC) prepared by incubation of immature (DC) with tumour lysate, while the second part contains an unattached fraction that is T-lymphocytes specifically activated by interleukin 2, mature (DC) and interleukine-1 cells.
EFFECT: use of the declared vaccine allows for effective oncotherapy.
2 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING AUTOLOGOUS TUBERCULOSIS VACCINE | 2008 |
|
RU2372936C1 |
| IMMUNOTHERAPY OF BREAST CANCER USING ANTIGEN-ACTIVATED DENDRITIC CELLS | 2016 |
|
RU2645464C1 |
| METHOD OF INDUCING CYTOTOXIC ANTI-TUMOUR IMMUNE RESPONSE in vitro WITH USING DENDRITIC CELLS, TRANSFECTED BY RNA TUMOUR CELLS, TO NON-SMALL CELL LUNG CANCER | 2015 |
|
RU2578008C1 |
| COMBINED CELL TRANSPLANT BASED ON LYMPHOKINE-ACTIVATED KILLERS AND DENDRITE CELLS, METHOD FOR PRODUCTION THEREOF AND METHOD FOR TREATMENT AND PROPHYLAXIS OF MALIGNANT, INFECTIVE DISEASES AND IMMUNODEFICIENT CONDITIONS | 2006 |
|
RU2309753C1 |
| GENERATION METHOD OF ANTIGEN-SPECIFIC CYTOTOXIC CELLS WITH ACTIVITY AGAINST OVARIAN CARCINOMA CELLS | 2012 |
|
RU2508298C2 |
| METHOD OF GENERATING CYTOTOXIC CELLS WITH ACTIVITY AGAINST NON-SMALL CELL LUNG CANCER CELLS | 2014 |
|
RU2577992C2 |
| METHOD OF GENERATING ANTIGEN-SPECIFIC CYTOTOXIC CELLS WITH ANTITUMOUR ACTIVITY IN BREAST CANCER | 2013 |
|
RU2521506C1 |
| METHOD FOR OBTAINING ANTIGEN SPECIFIC CYTOTOXIC CELLS WITH ANTI-TUMOR CYTOTOXIC ACTIVITY AGAINST CELLS OF NON-SMALL CELLS LUNG CANCER | 2016 |
|
RU2639514C1 |
| METHOD OF GENERATING ANTIGEN-SPECIFIC OF CYTOTOXIC CELLS WITH ANTICANCER ACTIVITY | 2011 |
|
RU2458985C1 |
| METHOD FOR OBTAINING OF MATURE ANTIGEN-ACTIVATED DENDRITIC CELLS WITH TRANSFECTION OF TUMOUR CELLS RNA OF BREAST CANCER | 2016 |
|
RU2631792C2 |
